Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy
出版年份 2022 全文链接
标题
Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy
作者
关键词
-
出版物
iScience
Volume 25, Issue 9, Pages 105019
出版商
Elsevier BV
发表日期
2022-08-28
DOI
10.1016/j.isci.2022.105019
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- C-type natriuretic peptide facilitates autonomic Ca2+ entry in growth plate chondrocytes for stimulating bone growth
- (2022) Yuu Miyazaki et al. eLife
- Mechanical load regulates bone growth via periosteal Osteocrin
- (2021) Haruko Watanabe-Takano et al. Cell Reports
- Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin
- (2021) Jialiang S. Wang et al. Nature Communications
- Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength
- (2020) Jerid W. Robinson et al. BONE
- A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
- (2020) Tadatoshi Sato et al. Nature Communications
- Denosumab vs risedronate in glucocorticoid-induced osteoporosis: final results of a 24-month randomized, double-blind, double-dummy trial
- (2019) Kenneth G. Saag et al. Arthritis & Rheumatology
- C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia
- (2019) Ravi Savarirayan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
- (2019) Sylvia Thiele et al. Endocrine Connections
- Genome-wide association study of extreme high bone mass: Contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes
- (2018) Celia L. Gregson et al. BONE
- Strain-specific differences in the development of bone loss and incidence of osteonecrosis following glucocorticoid treatment in two different mouse strains
- (2018) Kie Shidara et al. Journal of Orthopaedic Translation
- Glucocorticoid-Induced Osteoporosis
- (2018) Lenore Buckley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance
- (2017) Yugo Kanai et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis
- (2017) Tristan W. Fowler et al. Scientific Reports
- Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling
- (2017) Neha S. Dole et al. Cell Reports
- Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice
- (2016) Marilina Piemontese et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- SIKs control osteocyte responses to parathyroid hormone
- (2016) Marc N. Wein et al. Nature Communications
- Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice
- (2016) Adel Ersek et al. Scientific Reports
- The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytesin Vitro
- (2015) Jordan M. Spatz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: A systematic review
- (2015) Kareeann S. F. Khow et al. Journal of Nutrition Health & Aging
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Selective glucocorticoid receptor modulation maintains bone mineral density in mice
- (2012) Sylvia Thiele et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Glucocorticoid dose determines osteocyte cell fate
- (2011) Junjing Jia et al. FASEB JOURNAL
- Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid Receptor
- (2010) Alexander Rauch et al. Cell Metabolism
- Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
- (2010) Mary L Bouxsein et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Once-Weekly Oral Alendronate 70 mg in Patients with Glucocorticoid-Induced Bone Loss: A 12-Month Randomized, Placebo-Controlled Clinical Trial
- (2009) S. A. STOCH et al. JOURNAL OF RHEUMATOLOGY
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
- (2008) David S. Waddell et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice
- (2008) Wei Yao et al. ARTHRITIS AND RHEUMATISM
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started